Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading  Hajime Imura, MD, Hua Lin, MSc, Elinor.

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

L-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate  Tomohiro Mizuno, MD, Masazumi.
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat  Ryuzo Bessho, MD, PhD, David J. Chambers,
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation  Haitham J. Abunasra, FRCS,
Early reperfusion with warm, polarizing adenosine–lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage  Donna M. Rudd,
Functional evaluation of human donation after cardiac death donor hearts using a continuous isolated myocardial perfusion technique: Potential for expansion.
Terje K. Steigen, MD, Ellen Aasum, MS, Truls Myrmel, MD, PhDa, Terje S
Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia  Y.Joseph Woo, MD, Matthew D Taylor, BS,
Building a bioartificial heart: A 3-song saga
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
William M. DeCampli, MD, PhD 
A new approach: Ischemic mitral regurgitation guidelines by and for surgeons  Patrick M. McCarthy, MD  The Journal of Thoracic and Cardiovascular Surgery 
Philippe Menasché, MD, PhD 
The lord of the rings  Antonio Miceli, MD, PhD 
Continuous warm versus intermittent cold cardioplegic infusion: A comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity,
Normokalemic adenosine–lidocaine cardioplegia: Importance of maintaining a polarized myocardium for optimal arrest and reanimation  Kathryn L. Sloots,
Oral pretreatment with a green tea polyphenol for cardioprotection against ischemia– reperfusion injury in an isolated rat heart model  Shigeki Yanagi,
Myocardial metabolic changes during pediatric cardiac surgery: A randomized study of 3 cardioplegic techniques  P. Modi, FRCS, M.-S Suleiman, PhD, B Reeves,
Gastric conduit revision after esophagectomy: The raising of Lazarus
The variability of the mitral valve anatomy and terminology
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
A first start for lung transplantation?
Ashok Muniappan, MD  The Journal of Thoracic and Cardiovascular Surgery 
Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia  Stacy B. O’Blenes, MD, Camille Hancock Friesen, MD,
Jules Lin, MD  The Journal of Thoracic and Cardiovascular Surgery 
Dysfunction induced by ischemia versus edema: Does edema matter?
Experimental study of intermittent crossclamping with fibrillation and myocardial protection: Reduced injury from shorter cumulative ischemia or intrinsic.
Commentary: Faster recovery after complex neonatal cardiac surgery
Christopher M. Feindel, MD, MSc, Maral Ouzounian, MD, PhD 
Ischemic postconditioning promotes left ventricular functional recovery after cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion.
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Daniel T. Engelman, MD, FACS, Michael J. Germain, MD 
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
A fate worse than death  Jennifer S. Lawton, MD 
Manuel J. Antunes, MD, PhD, DSc 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia  Vivek Rao, MD, PhD, Frank Merante, PhD,
Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts  Annie Rochetaing,
Innovation in cardiothoracic surgical training
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
Avoiding reperfusion injury after limb revascularization: Experimental observations and recommendations for clinical application  Friedhelm Beyersdorf,
Keeping the heart empty and beating improves preservation of hypertrophied hearts for valve surgery  Jian Wang, MD, Hongyu Liu, MD, PhD, Bo Xiang, DDS,
The continuing challenge of congenital heart disease in China
Between a rock and a hard place
Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor  Yuka Uchiyama,
Early effects of hypothyroidism on the contractile function of the rat heart and its tolerance to hypothermic ischemia  Manuel Galiñanes, MD, PhD, Ryszard.
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Myocardial protection by ischemic preconditioning and δ-opioid receptor activation in the isolated working rat heart  Matthias Karck, MDa, Satonori Tanaka,
Insulin-induced improvement of postischemic recovery is abolished by inhibition of protein kinase C in rat heart  Ulrich Fischer-Rasokat, BS, Torsten.
Commentary: Avoiding acute kidney injury after cardiac operations: Searching for the holy grail is not easy  Victor A. Ferraris, MD, PhD  The Journal.
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance induced by limb remote ischemia preconditioning in rats  Binxiao Su, MD, Hailong Dong,
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Commentary: Just say NO
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Did you like Terminator 3 better than Terminator 2
Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation  Geoffrey P. Dobson, PhD, Michael W.
Presentation transcript:

Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading  Hajime Imura, MD, Hua Lin, MSc, Elinor J. Griffiths, PhD, M.-Saadeh Suleiman, PhD, DSc  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 6, Pages 1529-1537 (June 2011) DOI: 10.1016/j.jtcvs.2010.09.048 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Schematic presentation of the experimental protocols followed in this study. In control experiments, Langendorff-perfused juvenile (11-14 days) guinea-pig hearts were exposed to 30 or 45 minutes of normothermic global ischemia followed by reperfusion for 35 minutes with normal buffer. In the experimental protocols (intervention) hearts were exposed to 30 or 45 minutes of normothermic global ischemia followed by 2 or 5 minutes of controlled hyperkalemia reperfusion with or without Mg2+ (5, 10, 16, or 23 mM). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Effect of 16 mM Mg2+ during hyperkalemic controlled reperfusion on functional recovery (LVDP) and cardiac injury (LDH release) in isolated perfused juvenile hearts exposed to a mild ischemic insult. Measurements were made prior to ischemia and at different time points during reperfusion for LVDP (A) and LDH (B). Data are presented as mean ± SEM (n = 6/group). LVDP in the control group was significantly (P < .05) lower during reperfusion at all time points taken after 5 minutes. ∗P < .05 vs other groups at same time point. ∗∗P < .05 vs control at same time point. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Effect of different concentrations of extracellular Mg2+ during hyperkalemic controlled reperfusion in isolated perfused juvenile hearts exposed to a mild (A and B) or severe (C and D) ischemic insult. Functional recovery was calculated as the final measurement of RPP (rate pressure product) as percentage of basal level (A and C). Cardiac injury (total LDH release) is shown in B and D. Data are presented as mean ± SEM (n = 6/group). ∗P < .05 vs control. ∗∗P < .05 vs control and 20K+. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Effect of 16 mM Mg2+ during hyperkalemic controlled reperfusion on functional recovery (LVDP) and cardiac injury (LDH release) in isolated perfused juvenile hearts exposed to a severe (45-minute) ischemic insult. Measurements were made prior to ischemia (basal) and at different time points during reperfusion for LVDP (A) and LDH (B). Data are presented as mean ± SEM (n = 6/group). LVDP in the 20 K, 16 Mg group was significantly (P < .05) lower during reperfusion at all time points. ∗P < .05 vs other groups at same time point. ∗∗P < .05 vs control at same time point. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Effect of 16 mM Mg2+ during hyperkalemic controlled reperfusion on myocardial concentration of ATP (A and B) and lactate(C and D) in biopsies collected from isolated perfused juvenile hearts at the beginning (basal) and end of a mild (A and C) or severe (B and D) ischemic insult followed by 2 or 5 minutes of controlled reperfusion (intervention). Data are presented as mean ± SEM. ∗P < .05 vs basal level. ∗∗P < .05 vs corresponding basal and intervention levels. †P < .05 vs the -Mg2+ intervention group. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 Effect of 16 mM Mg2+ during hyperkalemic controlled reperfusion on intracellular Ca2+ concentration ([Ca2+]i) measured in isolated superfused cardiac myocytes exposed to mild or severe metabolic inhibition (see Methods). A, During severe metabolic inhibition myocytes enter rigor and [Ca2+]i increases markedly. On restoring normal perfusion conditions, [Ca2+]i declines back gradually but not to basal levels. Initial controlled hyperkalemic reperfusion with or without 16 mM Mg2+ for 5 minutes accelerated the recovery in [Ca2+]i. B, During mild metabolic inhibition, cell morphology and [Ca2+]i did not alter. However, restoring normal perfusion conditions induced a significant increase in [Ca2+]i. Controlled hyperkalemic reperfusion with Mg2+ for 2 minutes significantly prevented the rise in [Ca+2]i. However, [Ca2+]i remained significantly higher than basal levels at most time points. Data are presented as mean ± SE (n = 6/group). ∗P < .05 vs basal level. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1529-1537DOI: (10.1016/j.jtcvs.2010.09.048) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions